Jasper Gains 11% on Data for Briquilimab in Urticaria
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
The bull market in US stocks will enter its third year. The three major stock index futures show mixed movements before the market opens. | Tonight's highlights
①The Nasdaq 100 index futures rose more than 0.4% in pre-market trading; ②Apple is set to launch a $2000 Vision headset as early as next year; ③Taiwan Semiconductor plans to establish more chip factories in Europe; ④GlaxoSmithKline's experimental drug for treating rhinitis has shown positive results.
"Weight-loss miracle drug" causing muscle loss, biotechnology companies like Regeneron Pharmaceuticals (REGN.US) are developing new treatments.
Wegovy and Zepbound, along with other GLP-1 class drugs, have significant effects on weight loss, but this weight loss largely reduces muscle mass.
Weight Loss Drugs Have One Big Issue; These Companies Want to Fix It
Morgan Stanley Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,235